The effects of activators and inhibitors of prr tein kinase C (PKC) on the production of C-type natriuretic peptide (CNP) by cultured human aortic endothelial cells were examined. The PKC activators phorbol 12.myristate 13-acetate (PMA) and l-oleoyl 2-acetyl glycerol (OAG 1 stimu,ated CNP release; the maximal effects were apparent at 4 h, at which time release was 934 and 205% of the control value, respectively. Th: PKC inhibitors staurosporine and H-7 d.id not affect basal CNP release, but each aboli:.heJ ;:!c &crease in CNP release induced by PMA or OAG. PKC was activated and transiocated from cytosolic to membrane fractions in endothelial cells exposed to PMA oz OAG; the maximal effect was apparent at 1 h. PMA d':d OAG each increased the abundance of CNP mRNA, with the maximal effect at 2 h. These data suggest that activation of PKC by PMA or OAG results in an increase in the abundance of CNP mRNA and subsequent enhancement of CNP production and release in human aortic endothelial cells. Aur J Hypertens 1996; 9:924-929 KtY WOHDS: Human aortic endothelial cells, Ctype natriuretic pzptide, protein kinase C.
- EDTA rind aprotinin as before. The samples were CYtracted and lhc concentration of CNP was determined MATERIALS AND ME'I'HODS by radioimmunoassay (l'zijinsula Labora tories, Belmont, CA). After collection of the culture me'dium, the total proeein content of the endothelinl cells remaining in the ilask was measured, and the amount of CNP released was calculated as picograms per milligram of cellular protein.
Celi Culture Human aortic endothelial cells were obtained from Kurabo (Osakc, Japan) and cultured in MCDB-131 medium supplemented with penicillin (100 U/mL), streptomycin (IO:3 b,g/mL), bovine endothelial mitogen (100 ,~g/mL), heparin (100 pg/tnL), and 10% fetal bovine serum (complete culture medium) at 37°C in a humidified atmosphere of 95% air and 5% COz.'3," After brief exposure to C.25% trypsin and EDTA (0.5 rnmol/L), the cells were subcultured in T-75 flasks precoated with 0.1% gelatin.'.',"' All experimental data were obtained from endothclial c&s of the sixth passage. Before each experiment, the endothelial monolayers were carefully examined with a phase-contrast microscope and only tightly confluent cells were used.
Activation and Inhibition of PKC PKC was activated by the addition of phorbol 1Zmyristate j:3-ac&ate ,(PMA) (0.1 l,mol/ L) or I-oleoyl 2-acetyl glycerol (OAG) (0.1 mmol /L) to the er;dotheliaf monolayer. 4ry-Phorbol12,13-didecanoate (4a-PDD) (0.1 pmol/ L) al!d I-mono-o!eoyl glycerol (MOG) (0.1 mmolil) were tested as control reagents for PMA and OAG, resp&tively. Staurosporme (0.1 p,mol iL) was used as an inhibitor of PKC. These reagents were dissolved in dimethylsulfoxide, of which. the fical concentration in cell incubations was 0.05% to 0.1%. The PKC inhibitor H-7 and the control reagent HA-1004 we;e dissolved in H20 and added to cells at a finai concentration of 50 pnol/L.
None of tne reagents at the concentrations used in this study showed cytotoxicity, as judged by the absence of any significant relea-e of iactate dehydrogenase from the endothelial cells.
Assay of PKC Activity PKC activity w-13 assayed in cytosolic a!ld membrane fractions of human aortic endothelial cells. At various times (0, 0.5; 1 -,f, 6, or tc'h j of incubation of human aortic endolheliai ceils with PM.4 or OAG, cells were sc;-aped ir.t.3 buffer A 150 mmol /L Tris-HCl (pH 7.5), i0 mmol / L FDTA, 5 mmo! / L EGTA] containing the pratcase inhibitors phr~r,ylmetllylsulfonyl fluoride (1 mmol / L), iodoacetamide il mmol/L), benzamide (1 mmol/ I,), aprotinin (20 j&gimL) , !cupeptin (20 p,g/mL), pepstatin A (20 pg/mL), and antipain (20 pg/mL).'i The cell juspensions were passed five times through 23-gauge needies, and membrane and cytosolic fractions were separated by centrifugation at 10,000 s for 1 h aL 4°C. The membrane fraction was sn!ubilized ;n batfer A containing 0.5% Triton X-100, and the qrtosolic fractior, was also adju.sted to 0.5 ;n cl Tritoll X-lr)O~ PKC activity in each tiaction was assayed with a kit (PrepTag; Promega, Madison, WI) and was expressed as units per milligram of cellular protein. In the first series of experiments, after achieving con-kit; Pharmacia, Uppsafa, Sweden), qu.antitated by abtluence, the ceils were washed with MCDB-131 alone sorbance at 260 nm, and stored in ethanol at --P!YC. A and incubated with 10 mL of MCDB-131 containing portion (100 rtg) of poly(A\+ RNA frsm each cell samhuman albumin (1 mg/mL) and either one of the .est pie was incubated at 63'C for 5 min with oligo(dT) agents or vehicle for 15 min, 30 min, 1, 2, 4, 6, or S h. primers (0.3 pg), after which it was ccoled s!owly to After thorough washing with MCDB-131 alone, tl~~ allow annealing of the primers to thz RNA. The sample cells were incubated with medium containing only hu-was incubated at 37°C for 1 h wii-h Maloney murine m3n albumin (1 mg/mL) for 2 h. The medium was $ukemia virus reverse trdnscriptaje (50 U!, dNTPs (1 then collected into tubes containing EDTA (disodium mmol/ L), and ribcnuclease inhibitor (40 U) in a fi>al salt? 1.5 mg/mL) and aprotinin (500 kallikrein IU/mL) volume of 50 PL c0:ltainin.g 50 mm01 / L Tris-11CI (pH and s:orcd at -30°C. In the second series of expe:-i-8. release subsequently decreased and was 125% ~.ii con trol lrcel at X h. MCX;, an analog ot OAC that does not activate I'KC, had no effect on CNI' r&we (FigIll." IHi. 'i'hc effects c,C the I'KC inhibitors stnurosporinr and H-7, in the absence or prescncc ,if I'KC ngonisb:, were then investigated. Endothcli,:l monolayers were incubated with medium containing human albumin il mg/mL) and either IWA (0.1 pmol/ Ll, OAC ((I.1 mmoli Ll, or a PKC inhibitor t~taurosporine, 0.1 PmoI j L; or H-7 , XI pnwl ,'i.) in the ab~c~nce or presence of activator for 4 h, ait,zr which the nieci*ilm u a1y ;~'m~ed and replaced with medium c~ntainmg albumin alone; Ckl' rciki.4;: :*.flc measured ai:er 2 11. PSI.4 and, to a lesser but signific:mt cxtcnt, c::lC; again increased CNP release (l'igure 1C). Neithh!: staurosporinr nor H-7 affected basal Ck'l' rcle,~sc, but t.wh inhibited thr increase in C'Ni'rrlease induced by I'XI A ,,i WAG ( Figure 1C) . t IA-1004, a control rengcnt fog H-7. dni not affect CNI' release from endo?.wlial cells (F:grre iC).
In an attempt 11) explain the dixrepancy between the magnitudes oi the *:flccts of I'?&4 and OAC on CNI' release, we examined the extent of PKC actlvaLion induced b:< t!?fw agents bv assaying I'KC acti\pit;< in m,mbranc and cytosoltc iractions of tr-atcd cells ( Figure Zi . PKC activrty ii, the membrane fracuon was lciw in control cells (at 0 1-j hut incrr,iwJ ral:,.tly after cxpu~;iirc of cells to I'M~Z~ actj\~~tv \rds m,iximal at I h and ther:.\!ter dccrcastd X similar time. court ~a. apparent for I'KC activitv in the mcmbranc fraction of cnduth~*lia! cells stimtilatc~d with O;ZC The I'KC acti\.ity in the mcmbrant ' fraction 0i ~~vII~ stimulalc d with I'MA tor '\G min, I !>, or 2 h v\,rs significantly grcsatcr than that iorOAC;-stimulated cells at ~hc +lmc times. I'KC I c:ivity in the r.yttwilic tr.iction ~\'ns high in control cells fat 0 1~) but Jcireased rapidI!-ak exposure of crll~ to IWX or OAC;. Thcsc wsults show that PhIA and 0.4C induce translocatinn of I'KC ircm the cvtowi to mcmbrancs in human aortic endnthclial .F'lnally, to investigate the tjme delay between PKC actb&on and CNP secretion, we assayed CNP mRfdA.by RT-PCR in human aortic endotheiial cells stimulated with PMA or OAG (Figure 3 ). PMA and 'O-AC each 'increased the iritensity of the band cormspending to,the CNP RT-FCR product, with tile maximal effect apparent at 2 h in each instance. Although this approach is only semiquantitative, the increase. in .CNP mRNA induced by FMA appeared greater t!lan that induced by OAG. The abundance of GAPIX+ mRNA in endothelial cells was not affected by incuba-'$0~1 with PhlA or OAG.
DISbJSSlON
The production and secretion of CNP is an 'Tportant function of endothelial cells, giver. tha: this potent natriurctic prptide is thought to partic",late in vascular reniodrl~ng. " '*i7a~'" We have now studied the role of FKC in the regulation of CNF production by human 'aortic endothelial cells. Our data show that continuous exposure to PKC activators increased CNF synthesis and release from endothelial cells, with a maximal effect at 4 h.
PKC translocates from the cytosol to membranes as a result of stimulation of cells with phorbol esters such as PMA. We showed that maximal FKC, activity was apparent in membrane fractions of human aortic endothehal. cells exposed to FMA or OAG after i h, con-.sisten! with the results of previous studies.'**"' We did not detect a marked increase in CNP release in response -to PKC agonists until after 2 h. Analysis of CNP mRNA by RT-PCR demonstrated a maximal increase in transcript abundance 2 h after exposure of cells to PMA or OAG. Therefore, the delay between PKC .activation. and CNf' release is likely attributable 'to the time,requlred for transcription of the CNF gene and. protein biosynthesis. The increase in CNF production induced by PMA or OAG was ccrnpleteiy albolished by coincubation of cells with the PKC inhibitors staurosporine or H-7, consistent with the increase ;n synthesis of CNF being mediated by the activation .of PKC. The stimulation of CNP production and release was more marked with PMA than with OAG, which .is likely explained by the observation that PKC activity in membrane fractions of endothelial cells stimulated with PJUA' for 30 min to 2 h was signiBcantlv higher than th& in membrane fractions : of endotheJ&lcklls stimulated with OAG ior the corre-" sponding times. RT-FCR analysis also indicated that the increase in CNP mRNA induced by PMA was greater than that induced by OXC;. 1 Prolonged-exposure ,of'cells to activators of PKC tan result in down-regulation of:' the &izyn~e.'2~~6. When cells are exposed to PMA, activation of FKC in 'the membrane ,fraction continues for up to.8 h, ifter which dow'n-regulation is apparent for.16 to 24 hi2:16 ',, :-. A\H-SEPTEMBER 1996VOL. 9. NO. 9 Our resulk show that the peak effect (an approxil mately ninefold increase) of FMA on CNF release was apparent at 4 h, after which time CNP release decreased markedly. Suga et al.' showed that incubation. with PMA (1 pmol/L) for 24 h induced a threefold increase in CNP release from bovine carotid artery endothelial cells. However, because FKC may already be down-regulated after exposure of endothelial cells to F-MA for 24 h, this threefold increase may not be the maximal response. We showed that activation and translocation of PKC induced by PM,!. cr OAG were maximal at 1 h, the maximal mcrease in CNP mRNA was apparent at 2 h, and the release of CNF was maximal at 4 h in human aortic cndothelial cells. Our results indicate that activation of PKC increases CNF production by these cells.
